Category: COVID-19 / News / Insights - Page 2

Johnson & Johnson's single-dose vaccine protects COVID-19. This sets the stage for a final decision on a new, easier-to-use injection to control the pandemic.

More than 10 potential coronavirus vaccines’ clinical trials made it to Phase III, the last stage before regulatory agencies approval. The international community has its eyes especially on three of them: Pfizer, Moderna and Oxford-AstraZeneca. It should be remembered that Pfizer was the first vaccine approved by the WHO.